The Enterprise Value as of December 2024 (TTM) for Regenicin, Inc. (RGIN) is 15.35K

According to Regenicin, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 15.35K. This represents a change of -100.29% compared to the average of -5274139.05 of the last 4 quarters.

Regenicin, Inc. (RGIN) Historical Enterprise Value (quarterly & annually)

How has RGIN Enterprise Value performed in the past?

The mean historical Enterprise Value of Regenicin, Inc. over the last ten years is 3.63M. The current 15.35K Enterprise Value has changed -57.66% with respect to the historical average. Over the past ten years (40 quarters), RGIN's Enterprise Value was at its highest in in the March 2017 quarter at 21.60M. The Enterprise Value was at its lowest in in the December 2022 quarter at -11074241.47.

Regenicin, Inc. (RGIN) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Regenicin, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Regenicin, Inc. (RGIN) Average Enterprise Value

How has RGIN Enterprise Value performed in the past?

The current Enterprise Value of Regenicin, Inc. (RGIN) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Regenicin, Inc. (RGIN) Enterprise Value vs. Peers

How is RGIN’s Enterprise Value compared to its peers?

Regenicin, Inc.’s Enterprise Value is less than Denali Therapeutics Inc. (2.93B), less than Cardiff Oncology, Inc. (263.37M), less than CytoDyn Inc. (150.01M), less than Onconova Therapeutics, Inc. (24.94M), greater than Inovio Pharmaceuticals, Inc. (-9176078000.00), less than ImmunoGen, Inc. (8.19B), less than Mustang Bio, Inc. (5.72M), less than Coya Therapeutics, Inc. (60.50M), less than REGENXBIO Inc. (385.66M), less than BridgeBio Pharma, Inc. (6.83B), less than Atea Pharmaceuticals, Inc. (175.34M), less than Krystal Biotech, Inc. (4.13B),

Build a custom stock screener for Regenicin, Inc. (RGIN) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Regenicin, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Regenicin, Inc. (RGIN) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Regenicin, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.